Clinical trial · Observational
Study of Prognostic Factors in Adult Lymphoblastic Lymphoma
FPLLA-PETHEMA-001: Study of Prognostic Factors in Adult Lymphoblastic Lymphoma
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Retrospective observational study with systematic collection of data on filiation (age at diagnosis and sex), clinical data (IPI, ECOG, early response to chemotherapy, overall response to chemotherapy), biological (strain B or T, infiltration of the nervous system central \[CNS\], bone marrow \[MO\], lactate dehydrogenase (LDH) level at the time of diagnosis, as well as genetic patients included in the study, as well as the PETHEMA protocol used in the treatment of same patients The study will review the PETHEMA protocols from 2003 to the present
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lymphoblastic Lymphoma | Lymphoblastic Lymphoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Description pronostic factors
- timeFrame
- 1 year
- description
- Study of the main clinical-biological variables as independent risk factors in adult patients (\> 15 years) diagnosed with ALL
Secondary outcomes (2)
- measure
- overall survival
- timeFrame
- 1 year
- description
- To study if there has been an increase in overall survival (OS), in patients diagnosed with ALL in the different PETHEMA protocols
- measure
- Progression free survival
- timeFrame
- 1 year
- description
- To study if there has been an increase in progression-free survival (PFS) in patients diagnosed with ALL in the different PETHEMA protocols
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 15 Years
Show eligibility criteria text
Inclusion Criteria: Patients \>15 years old diagnosed with ALL and treated with the PETHEMA protocols for ALL Exclusion Criteria: None
References
Publications (0)
Data not yet available